Patents by Inventor Patrick S. Ward

Patrick S. Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11950390
    Abstract: An electrical conductor assembly for use in a power distribution assembly includes an electrical conductor and a casing covering at least a portion of the electrical conductor. A spring member is mounted to the casing and configured to apply a compressive force to the electrical conductor.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: April 2, 2024
    Assignee: EATON INTELLIGENT POWER LIMITED
    Inventors: Joel Anthony Furco, Andrew Francis Scarlata, Joseph M. Manahan, Patrick S. Ward
  • Publication number: 20240097384
    Abstract: An electrical conductor assembly for use in a power distribution assembly includes an electrical conductor. A casing covers at least a portion of the electrical conductor. The casing insulates the at least a portion of the electrical conductor.
    Type: Application
    Filed: November 29, 2023
    Publication date: March 21, 2024
    Inventors: Joel Anthony Furco, Joseph M. Manahan, Patrick S. Ward
  • Patent number: 11870187
    Abstract: An electrical conductor assembly for use in a power distribution assembly includes an electrical conductor. A casing covers at least a portion of the electrical conductor. The casing insulates the at least a portion of the electrical conductor.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: January 9, 2024
    Assignee: EATON INTELLIGENT POWER LIMITED
    Inventors: Joel Anthony Furco, Joseph M. Manahan, Patrick S. Ward
  • Patent number: 11262362
    Abstract: The present invention provides biomarkers for sensitive, specific, accurate and quantitative diagnosis and assessment of chronic hypoxia. In particular, the present invention provides 2-hydroxyglutarate as a biomarker that is differentially produced in chronic hypoxia. Furthermore, embodiments of the invention are able to differentiate between chronic and acute hypoxia. Assays for levels of 2-hydroxyglutarate may be used alone or in conjunction with additional biomarkers of hypoxia to increase the precision of analysis. In particular embodiments of the invention, the level of 2-hydroxyglutarate and at least one second biomarker may be assayed to generate a hypoxic profile that can be compared to a reference or control profile, thereby diagnosing a subject as normoxic, chronically hypoxic, or acutely hypoxic.
    Type: Grant
    Filed: November 18, 2012
    Date of Patent: March 1, 2022
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: David R. Wise, Patrick S. Ward, Craig B. Thompson
  • Publication number: 20210126408
    Abstract: An electrical conductor assembly for use in a power distribution assembly includes an electrical conductor. A casing covers at least a portion of the electrical conductor. The casing insulates the at least a portion of the electrical conductor.
    Type: Application
    Filed: October 28, 2020
    Publication date: April 29, 2021
    Inventors: Joel Anthony Furco, Joseph M. Manahan, Patrick S. Ward
  • Publication number: 20210127521
    Abstract: An electrical conductor assembly for use in a power distribution assembly includes an electrical conductor and a casing covering at least a portion of the electrical conductor. A spring member is mounted to the casing and configured to apply a compressive force to the electrical conductor.
    Type: Application
    Filed: October 28, 2020
    Publication date: April 29, 2021
    Inventors: Joel Anthony Furco, Andrew Francis Scarlata, Joseph M. Manahan, Patrick S. Ward
  • Publication number: 20160033533
    Abstract: The present invention provides biomarkers for sensitive, specific, accurate and quantitative diagnosis and assessment of chronic hypoxia. In particular, the present invention provides 2-hydroxyglutarate as a biomarker that is differentially produced in chronic hypoxia. Furthermore, embodiments of the invention are able to differentiate between chronic and acute hypoxia. Assays for levels of 2-hydroxyglutarate may be used alone or in conjunction with additional biomarkers of hypoxia to increase the precision of analysis. In particular embodiments of the invention, the level of 2-hydroxyglutarate and at least one second biomarker may be assayed to generate a hypoxic profile that can be compared to a reference or control profile, thereby diagnosing a subject as normoxic, chronically hypoxic, or acutely hypoxic.
    Type: Application
    Filed: November 28, 2012
    Publication date: February 4, 2016
    Inventors: David R. Wise, Patrick S. Ward, Craig B. Thompson
  • Publication number: 20140314728
    Abstract: The present invention provides biomarkers for sensitive, specific, accurate and quantitative diagnosis and assessment of chronic hypoxia. In particular, the present invention provides 2-hydroxyglutarate as a biomarker that is differentially produced in chronic hypoxia. Furthermore, embodiments of the invention are able to differentiate between chronic and acute hypoxia. Assays for levels of 2-hydroxyglutarate may be used alone or in conjunction with additional biomarkers of hypoxia to increase the precision of analysis. In particular embodiments of the invention, the level of 2-hydroxyglutarate and at least one second biomarker may be assayed to generate a hypoxic profile that can be compared to a reference or control profile, thereby diagnosing a subject as normoxic, chronically hypoxic, or acutely hypoxic.
    Type: Application
    Filed: November 18, 2012
    Publication date: October 23, 2014
    Inventors: David R. Wise, Patrick S. Ward, Craig B. Thompson